Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Conventional and Alternative Pain Treatment Markets
... and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights ... Read More
-
Global Opioid Narcotics Market Growth 2024-2030
... cases, for anesthesia. These drugs bind to opioid receptors in the central nervous system to exert a variety of effects such as analgesia and sedation. The global Opioid Narcotics market size is projected to grow ... Read More
-
Drug Wholesalers
... the US), as well as Jointown Pharmaceutical (China), Medipal (Japan) and PHOENIX (Germany). COMPETITIVE LANDSCAPE Demand for pharmaceutical distribution is driven by the need to treat illness and disease. The profitability of individual companies is ... Read More
-
Endocrinology Drugs Market by Therapy Area (Adrenal Insufficiency, Diabetes, Growth Hormone Disorders, Other Therapy Areas), Drug Class, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... The global endocrinology drugs market size was valued at $98.31 billion in 2024 and is projected to reach $145.89 billion by 2030, growing at a CAGR of 6.8% during the forecast period. Endocrinology Drugs Market ... Read More
-
Dermatology Drugs Market by Type (Cosmetic Dermatology, Cutaneous Lymphoma, Other Types), Route of Administration, Indication, Distribution Channel, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... The global dermatology drugs market size was valued at $33.39 billion in 2024 and is projected to reach $62.45 billion by 2030, growing at a CAGR of 11.0% during the forecast period. Dermatology Drugs Market ... Read More
-
Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... global idiopathic pulmonary fibrosis treatment market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global idiopathic pulmonary fibrosis ... Read More
-
Genitourinary Drugs
... at a CAGR of 2.4% over the analysis period 2023-2030. Urologicals, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$10.7 Billion by the end of the ... Read More
-
Motion Sickness Treatment
... by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Anticholinergic Treatment, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$532.7 Million by ... Read More
-
Chronic Myelogenous Leukemia Treatment
... reach US$10.1 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and ... Read More
-
Alzheimers Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 3.52 billion in 2022, and the market is now projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period of 2023-2030. ... Read More
-
Constipation Treatment
... at a CAGR of 5.9% over the analysis period 2023-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the ... Read More
-
Cryptococcosis Treatment
... at a CAGR of 4.5% over the analysis period 2023-2030. Amphotericin B Treatment, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$5.5 Billion by the end ... Read More
-
Desmopressin
... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Fondaparinux
... of 5.3% over the analysis period 2023-2030. Generic Fondaparinux, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$643.5 Million by the end of the analysis period. ... Read More
-
Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Epilepsy Therapeutics Market (2024 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By ... Read More
-
Focal Segmental Glomerulosclerosis
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Primary Disease Type, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$17.9 Billion ... Read More
-
Acne Drugs
... at a CAGR of 6.8% over the analysis period 2023-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$9.6 Billion by the end of ... Read More
-
Veterinary Pain Management
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$2.1 Billion ... Read More
-
Glioblastoma Multiforme Treatment (GBM)
... reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
Gamma Oryzanol
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Sports Supplement Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach 11.3 Thousand ... Read More
-
Somatostatin Analogs
... at a CAGR of 5.8% over the analysis period 2023-2030. Octreotide, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$5.0 Billion by the end of the ... Read More
-
Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Online Pharmacy Market (2024 Edition)” which provides a complete analysis of the Global Online Pharmacy industry in terms of market segmentation by Drug Type (Over the Counter (OTC) Drugs, ... Read More
-
Pharmacokinetics Services
... at a CAGR of 6.5% over the analysis period 2023-2030. Small Molecules, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Corticosteroids Therapy
... at a CAGR of 4.6% over the analysis period 2023-2030. Glucocorticoids, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
Influenza Medication
... at a CAGR of 1.9% over the analysis period 2023-2030. Zanamivir, one of the segments analyzed in the report, is expected to record a 1.2% CAGR and reach US$123.9 Million by the end of the ... Read More
Research Assistance
